Jack has been part of the teams advising:
- Avista Public Acquisition Corp. II, a SPAC sponsored by Avista Acquisition LP II (an affiliate of Avista Capital Holdings), in its pending $850 million business combination with OmniAb, Inc.
- Covetrus, Inc. in its $4 billion sale to CD&R, a holder of approximately 24% of Covetrus' outstanding common stock, and TPG
- Thea Pharma Inc. (a subsidiary of Laboratoires Théa SAS) in its acquisition of a portfolio of seven ophthalmic products from Akorn Pharmaceuticals
Jack joined Weil as a summer associate in 2020.
Jack received his J.D., magna cum laude, from Boston College Law School, where he served as a Senior Editor of the Boston College Law Review, and his B.A., cum laude, from the College of the Holy Cross.